A Bioequivalence Study Between Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals vs. FLOVENT DISKUS ® 250 mcg/Blister Oral Inhalation Powder /GSK in Healthy Volunteers Under Fasting Conditions
Conditions: Asthma; Bioequivalence Interventions: Drug: Fluticasone Propionate 250 mcg/Blister Oral Inhalation Powder/Respirent Pharmaceuticals; Drug: FLOVENT DISKUS Sponsors: Respirent Pharmaceuticals Co Ltd.; Becro Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 31, 2022 Category: Research Source Type: clinical trials
To Study Generic Fluticasone Propionate Inhalation Aerosol for the Treatment of Bronchial Asthma
Condition: Bronchial Asthma Interventions: Drug: Fluticasone propionate Inhalation Aerosol 44 mcg; Drug: FLOVENT HFA 44 mcg; Drug: Matching Placebo inhaler Sponsor: Glenmark Pharmaceuticals Ltd. India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2022 Category: Research Source Type: clinical trials